CCRN Stock Charts

Quarterly

Annual

Unit: USD	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2003-09-30

cash flows from operating activities
consolidated net income	-4,774,000	-6,659,000	-490,000	-3,753,000	2,555,000	-16,050,000	2,692,000	9,038,000	12,812,000	21,345,000	29,436,000	38,791,000	34,793,000	52,894,000	61,983,000	77,573,000	23,433,000	11,548,000	19,448,000	4,822,000	-1,148,000	-14,048,000	-1,768,000	-600,000	-2,697,000	-51,270,000	-1,376,000	-19,343,000	-118,000	1,824,000	1,920,000	28,256,000	7,044,000	5,220,000	-1,718,000	-7,649,000	14,289,000	-17,095,000	19,186,000	-5,927,000	5,151,000	2,680,000	3,050,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	4,088,000	4,101,000	4,772,000	4,341,000	4,498,000	4,719,000	4,642,000	4,471,000	4,540,000	4,432,000	4,904,000	3,162,000	3,214,000	3,481,000	2,719,000	2,720,000	2,680,000	2,199,000	2,253,000	2,199,000	3,247,000	3,929,000	3,296,000	4,627,000	2,907,000	3,557,000	2,984,000	3,016,000	2,892,000	2,963,000	2,909,000	2,849,000	2,849,000	2,285,000	2,191,000	2,213,000	2,092,000	2,465,000	2,412,000	2,217,000	1,935,000	1,972,000	1,942,000
benefit from allowances	-959,000	-200,000	-135,000	-719,000	1,422,000	18,914,000	1,170,000	3,816,000	3,732,000	3,636,000	6,171,000	5,312,000	2,803,000	4,034,000	3,179,000	2,663,000	1,909,000	832,000	1,095,000	914,000	1,173,000	1,301,000	881,000	689,000	592,000	992,000	970,000	2,316,000	1,287,000	1,700,000	671,000	1,634,000	1,136,000	897,000	1,038,000	764,000	1,016,000	1,456,000	798,000	229,000	908,000
deferred income tax benefit	-1,240,000	623,000	-680,000			-3,225,000	-809,000																													567,000																-8,120,000	-5,680,000	-463,000		-100,000	-390,000	-158,000		-213,000	-275,000	-476,000
non-cash lease expense	244,000	252,000	250,000	261,000	257,000	233,000	241,000	288,000	288,000	283,000	252,000	413,000	432,000	438,000	567,000	558,000	582,000	662,000	622,000	615,000	675,000	1,066,000	1,191,000	1,190,000	1,275,000	1,270,000	1,254,000
impairment charges				2,170,000	0	114,000	604,000	0	186,000			0	3,856,000	0	1,741,000	0	0			166,000	1,071,000			0	1,804,000											0	0														11,900,407
equity compensation	766,000	870,000	1,318,000	1,698,000	870,000	2,259,000	1,198,000	1,166,000	1,433,000	2,205,000	1,775,000	2,187,000	1,491,000	2,114,000	1,601,000	1,637,000	1,771,000	2,137,000	1,349,000	1,340,000	1,064,000	2,072,000	927,000	879,000	982,000	1,004,000	531,000	1,211,000	981,000	914,000	469,000	997,000	1,068,000	1,278,000	737,000	765,000	847,000	1,119,000	648,000	687,000	557,000	840,000	376,000	416,000	90,000	452,000
other non-cash costs	207,000	204,000	202,000	-512,000	206,000	202,000	203,000	249,000	345,000	342,000	316,000	135,000			446,000	995,000	61,000	143,000	629,000	530,000	153,000	164,000	143,000	-910,000	-205,000	802,000	365,000	2,456,000	124,000	329,000	322,000		486,000	11,000	11,000		1,000				1,000
changes in operating assets and liabilities:
accounts receivable	22,446,000	18,294,000	3,584,000	22,468,000	-4,076,000	96,211,000	13,724,000	34,204,000	70,780,000	138,556,000	7,887,000	-26,226,000	88,227,000	-28,529,000	-186,701,000	-195,533,000	-46,613,000	307,000	-76,581,000	-2,148,000	-13,839,000	7,396,000	3,846,000	124,000	-20,417,000	3,251,000	10,400,000	75,000	-6,063,000	-3,790,000	12,598,000	6,371,000	-12,446,000	4,966,000	10,817,000	-27,210,000	-3,580,000	-2,491,000	2,500,000	-14,781,000	-5,793,000	-28,000	-8,106,000	-2,003,000	2,699,000	-11,897,000	-3,285,613	5,644,000	5,110,000	-5,432,000	739,589	-2,744,000	-126,000	-2,125,000	2,130,838	-4,762,000	-1,392,000	-3,950,000	1,942,796	-2,312,000	2,806,000	3,020,000	-75,217	12,581,000	21,994,000	13,238,000	6,192,354	4,913,000	7,470,000	680,000	7,284,988	-6,988,000	2,125,000	-2,337,000	-7,792,803	-6,503,000	5,778,000	4,843,000	-3,949,664	-3,082,000	-1,421,000	-5,171,000	3,916,571	1,211,000	2,597,000
prepaid expenses and other assets	2,054,000	-691,000	57,000	-5,612,000	1,698,000	151,000	-1,227,000	-2,975,000	-129,000	3,843,000	-471,000	-8,151,000	1,660,000	133,000	-557,000	-3,105,000	-195,000	-632,000	568,000	-2,374,000	847,000	180,000	-736,000	-3,057,000	1,510,000	1,450,000	-1,477,000	-1,369,000	-146,000	-522,000	-477,000	705,000	832,000	543,000	-264,000	-846,000	-1,601,000	670,000	-105,000	884,000	321,000	860,000	598,000
income taxes	1,733,000	663,000	4,549,000	-1,334,000	89,000	-2,326,000	1,293,000	-967,000	-415,000	-1,560,000	9,897,000	-6,891,000	-4,199,000	-31,071,000	22,050,000																					-21,000	189,000	-413,000	-252,000	782,000	-78,000	-416,000	87,000	-1,119,000	-397,000	-2,239,000	1,512,599	-164,000	-728,000	-759,000	1,606,750	1,195,000	-863,000	-190,000	-2,178,374	1,598,000	4,684,000	207,000	-8,961,266	926,000	6,744,000	496,000	-9,915,665	2,502,000	451,000	1,578,000	-6,109,691	1,317,000	52,000	2,491,000
accounts payable and accrued expenses	-3,449,000	-12,681,000	-9,173,000	3,839,000	-333,000	-17,767,000	-15,492,000	-37,015,000	-23,048,000	-54,557,000	-11,991,000	-7,444,000	8,718,000	15,459,000	62,979,000	46,611,000	14,661,000	-4,493,000	26,507,000	-3,149,000	-1,519,000	841,000	11,066,000	-9,105,000	128,000	4,828,000	2,841,000	-5,420,000	3,255,000	856,000	-5,786,000	-4,020,000	3,194,000	7,638,000	-16,087,000	14,736,000	10,641,000	1,061,000	-6,068,000	3,388,000	6,635,000	-1,630,000	2,820,000	-1,578,000	2,630,000	2,190,000	18,144	-1,572,000	-5,022,000	6,256,000	1,834,000	2,005,000	630,000	-341,000	-3,854,931	1,864,000	2,170,000	1,163,000	-1,070,573	519,000	-1,096,000	1,360,000	-3,658,928	-4,554,000	-6,525,000	3,368,000	-11,891,174	-780,000	-1,302,000	-905,000	-3,749,094	1,688,000	-2,828,000	-3,438,000	-643,755	7,913,000	-10,949,000	-4,664,000	2,165,558	3,190,000	17,619,000	128,000	-1,433,084	-786,000
operating lease liabilities	-652,000	-578,000	-562,000	-563,000	-652,000	-791,000	-785,000	-812,000	-1,406,000	-1,069,000	-1,084,000	-1,145,000	-1,143,000	-1,401,000	-1,273,000	-2,161,000	-1,227,000	-2,250,000	-1,115,000	-1,478,000	-1,482,000	-1,445,000	-1,467,000	-1,465,000	-1,523,000	-1,433,000	-1,399,000
other	-350,000	19,000	1,989,000	948,000	-152,000	-243,000	-1,443,000	-63,000	73,000	-571,000	370,000	96,000	1,089,000	-1,624,000	-200,000	7,401,000	233,000	59,000	298,000	774,000	1,288,000	797,000	-248,000	135,000	1,364,000	898,000	-1,227,000	-494,000	-475,000	-352,000	-1,014,000	2,337,000	-581,000	-769,000	-1,000,000													58,000	57,000	61,000
net cash from operating activities	20,114,000	4,217,000	5,681,000	24,234,000	7,470,000	82,401,000	6,011,000	12,074,000	70,311,000	119,248,000	46,865,000	4,320,000	140,627,000	18,141,000	-29,038,000	-73,365,000	-2,831,000	15,505,000	-24,927,000	1,929,000	-8,456,000	16,569,000	17,162,000	-5,351,000	-14,249,000	12,355,000	12,787,000	-760,000	3,818,000	4,666,000	13,273,000	16,803,000	3,180,000	24,115,000	1,410,000	-2,124,000	19,402,000	10,303,000	2,564,000	-631,000	12,869,000	5,727,000	270,000	2,475,000	3,703,000	-9,234,000	-2,899,988	7,161,000	5,913,000	-1,515,000		1,903,000	2,402,000	1,401,000	3,666,200	3,254,000	10,003,000	1,373,000	6,736,573	1,111,000	13,400,000	10,274,000	2,443,282	19,466,000	24,835,000	25,575,000	10,061,173	13,760,000	15,837,000	11,335,000	18,637,949	8,696,000	10,187,000	-1,557,000	3,206,670	9,610,000	9,871,000	10,230,000	9,924,330	11,214,000	6,326,000	3,326,000	6,284,361	10,266,000	14,900,000
capex	-2,191,000	-1,967,000	-1,886,000	-2,531,000	-1,124,000	-2,849,000	-2,210,000	-2,875,000	-3,425,000	-3,996,000	-3,678,000	-2,023,000	-2,915,000	-1,752,000	-2,096,000	-2,280,000	-1,888,000	-1,816,000	-1,186,000	-956,000	-1,169,000	-1,528,000	-962,000	-898,000	-478,000	-455,000	-1,109,000	-1,192,000	-1,116,000	-1,286,000	-1,003,000	-1,068,000	-657,000	-2,296,000	-1,090,000	-1,498,000	-2,408,000	-1,634,000	-982,000	-572,000	-757,000	-451,000	-582,000	-929,000	-261,000	-2,588,000	-1,074,663	-249,000	-195,000	-232,000		-425,000	-1,233,000	-462,000	-1,000,129	-808,000	-1,353,000	-837,000	-1,137,101	-573,000	-410,000	-271,000	-351,769	-459,000	-668,000	-974,000	-1,301,610	-1,113,000	-1,468,000	-806,000	-1,619,884	-3,130,000	-1,698,000	-1,830,000	0	0	0	0	0	0	-1,924,000	-2,099,000	-617,679	-1,073,000	0
free cash flows	17,923,000	2,250,000	3,795,000	21,703,000	6,346,000	79,552,000	3,801,000	9,199,000	66,886,000	115,252,000	43,187,000	2,297,000	137,712,000	16,389,000	-31,134,000	-75,645,000	-4,719,000	13,689,000	-26,113,000	973,000	-9,625,000	15,041,000	16,200,000	-6,249,000	-14,727,000	11,900,000	11,678,000	-1,952,000	2,702,000	3,380,000	12,270,000	15,735,000	2,523,000	21,819,000	320,000	-3,622,000	16,994,000	8,669,000	1,582,000	-1,203,000	12,112,000	5,276,000	-312,000	1,546,000	3,442,000	-11,822,000	-3,974,651	6,912,000	5,718,000	-1,747,000		1,478,000	1,169,000	939,000	2,666,071	2,446,000	8,650,000	536,000	5,599,472	538,000	12,990,000	10,003,000	2,091,513	19,007,000	24,167,000	24,601,000	8,759,563	12,647,000	14,369,000	10,529,000	17,018,065	5,566,000	8,489,000	-3,387,000	3,206,670	9,610,000	9,871,000	10,230,000	9,924,330	11,214,000	4,402,000	1,227,000	5,666,682	9,193,000	14,900,000
cash flows from investing activities
purchases of property and equipment	-2,191,000	-1,967,000	-1,886,000	-2,531,000	-1,124,000	-2,849,000	-2,210,000	-2,875,000	-3,425,000	-3,996,000	-3,678,000	-2,023,000	-2,915,000	-1,752,000	-2,096,000	-2,280,000	-1,888,000	-1,816,000	-1,186,000	-956,000	-1,169,000	-1,528,000	-962,000	-898,000	-478,000	-455,000	-1,109,000	-1,192,000	-1,116,000	-1,286,000	-1,003,000	-1,068,000	-657,000	-2,296,000	-1,090,000	-1,498,000	-2,408,000	-1,634,000	-982,000	-572,000	-757,000	-451,000	-582,000	-929,000	-261,000	-2,588,000	-1,074,663	-249,000	-195,000	-232,000	-98,877	-425,000	-1,233,000	-462,000	-1,000,129	-808,000	-1,353,000	-837,000	-1,137,101	-573,000	-410,000	-271,000	-351,769	-459,000	-668,000	-974,000	-1,301,610	-1,113,000	-1,468,000	-806,000	-1,619,884	-3,130,000	-1,698,000	-1,830,000							-1,924,000	-2,099,000	-617,679	-1,073,000
net cash from investing activities	-2,191,000	-1,967,000	-1,886,000	-2,531,000	-1,124,000	-2,849,000	-2,210,000	-2,875,000	-3,408,000	-3,996,000	-3,496,000	-37,111,000	-2,915,000	-1,752,000	-2,096,000	-4,686,000	-1,888,000	-26,286,000	-1,186,000	-956,000	-1,169,000	-1,528,000	-962,000	-898,000	-368,000	-429,000	-1,245,000	-3,124,000	-1,239,000	-1,288,000	-1,027,000	-1,121,000	-86,873,000	-2,296,000	-1,090,000	-3,398,000	-1,908,000	-3,769,000	-705,000	-29,319,000	6,282,000	-451,000	-582,000	3,269,000	-45,620,000	-2,588,000	-29,823,344	-442,000	-362,000	45,832,000	2,500,626	-477,000	-1,298,000	-551,000	-1,050,036	-856,000	-1,410,000	-880,000	-1,217,609	-1,474,000	-13,236,000	-271,000	-351,800	-472,000	-8,182,000	-999,000	154,360	-114,310,000	-5,969,000	-9,436,000	-91,095	-22,249,000	-10,643,000	-2,345,000	-5,291,519	-18,709,000	-2,297,000	-1,550,000	-1,658,519	-1,915,000	-1,924,000	-2,915,000	9,651,195	-1,141,000
cash flows from financing activities
borrowings under senior secured asset-based revolving credit facility	356,000	355,000	373,000	353,000	352,000	3,153,000	14,166,000	55,606,000	111,966,000	205,985,000	347,434,000	424,222,000	375,696,000	484,936,000	415,176,000																					2,600,000	0	0	57,200,000	25,300,000	4,500,000	13,000,000	21,300,000
repayments on senior secured asset-based revolving credit facility	-356,000	-355,000	-373,000	-353,000	-352,000	-3,153,000	-14,166,000	-55,606,000	-142,966,000	-241,385,000	-357,834,000	-356,622,000	-451,496,000	-451,438,000	-372,874,000																					-2,600,000	0	-6,000,000	-59,200,000	-17,300,000	-7,500,000	-16,500,000	-18,300,000
cash paid for shares withheld for taxes	-6,000			0	-6,000	-248,000	-2,706,000	-13,000	-5,000	-372,000	-4,514,000	0	0	-239,000	-5,028,000	0	0	-204,000	-2,026,000																	-314,000	-38,000
stock repurchase and retirement	0	0	-314,000	-4,077,000	-11,920,000	-14,945,000	-6,368,000	-6,403,000	-14,768,000	-4,723,000	-31,760,000	-10,937,000																0	-300,000	-1,815,000	-2,885,000																				-248	0	0	-374,000													-405	0	-664,000	-10,111,000	-4,873,876	-1,836,000	-1,847,000	-2,325,000	-84,293	-1,216,000	-798,000	-666,000	-1,951,324
payment of contingent consideration	0	0	-4,411,000	0	0	0	-6,579,000	0				0																								0	-135,000	0	-17,000
net cash from financing activities	-6,000	-1,756,000	-4,725,000	-4,077,000	-11,926,000	-15,193,000	-15,653,000	-6,416,000	-53,273,000	-114,871,000	-46,681,000	6,075,000	-107,661,000	-17,321,000	31,308,000	78,225,000	-12,569,000	15,434,000	38,004,000	-2,827,000	6,818,000	-21,402,000	-4,599,000	-2,186,000	-735,000	-5,383,000	-9,295,000	-8,176,000	-7,025,000	-3,417,000	-5,149,000	-915,000	60,527,000	-1,273,000	-7,583,000	-548,000	-1,024,000	1,838,000	-2,430,000	7,831,000	-3,211,000	-4,043,000	2,778,000	-7,294,000	44,081,000	10,858,000	8,321,680	-102,000	-425,000	-33,856,000	-1,248,920	-2,946,000	-3,662,000	-2,726,000	-6,155,220	-4,010,000	-2,454,000	-1,617,000	-1,618,315	-1,245,000	-3,056,000	-5,272,000	-5,574,084	-18,483,000	-24,442,000	-15,637,000	-12,478,901	108,496,000	-8,543,000	-7,397,000	-9,480,317	13,553,000	456,000	3,902,000	2,084,849	9,041,000	-9,071,000	-7,125,000	-8,265,811	-9,299,000	-4,402,000	-411,000	-15,935,556	-9,125,000	-10,105,000
effect of exchange rate changes on cash	22,000	2,000	-6,000					10,000			-1,000	0	-10,000	3,000	-2,000	20,000	3,000	-14,000	-3,000	8,000	19,000	-4,000	-34,000	9,000	-20,000	1,000	20,000	14,000	-48,000	-23,000	-13,000	5,000	-5,000	-11,000	34,000	-7,000	8,000	-19,000	-6,000	-12,000	-35,000	-19,000	4,000	-11,000	-29,000	67,000	3,573	-79,000	-116,000	-19,000	-61,179	145,000	-181,000	174,000	-117,573	-92,000	12,000	25,000	-75,812	148,000	-113,000	5,000	48,606	-45,000	239,000	-25,000	-201,328	-121,000	-38,000	-43,000
change in cash and cash equivalents	17,939,000	496,000	-936,000	17,612,000	-5,580,000	64,359,000	-11,852,000	2,793,000	13,628,000	382,000	-3,313,000	-26,716,000	30,041,000	-929,000	172,000	194,000	-17,285,000	4,639,000	11,888,000	-1,846,000	-2,788,000	-6,365,000	11,567,000	-8,426,000	-15,372,000	6,544,000	2,267,000	-12,046,000	-4,494,000	-62,000	7,084,000	14,772,000	-23,171,000	20,535,000	-7,229,000	-6,077,000	16,478,000	8,353,000	-577,000	-22,131,000	15,905,000	1,214,000	2,470,000	-1,561,000	2,135,000	-897,000	-24,398,079	6,538,000	5,010,000	10,442,000	5,630,657	-1,375,000	-2,739,000	-1,702,000	-3,656,629	-1,704,000	6,151,000	-1,099,000			-3,005,000	4,736,000		466,000	-7,550,000	8,914,000	-2,464,696	7,825,000	1,287,000	-5,541,000							-1,497,000	1,555,000
cash and cash equivalents at beginning of period	0	0	81,633,000		0	0	17,094,000		0	0	3,604,000		0	0	1,036,000		0	0	1,600,000		0	0	1,032,000		0	0	16,019,000		0	0	25,537,000		0	0	20,630,000		0	0	2,453,000		0	0	4,995,000	0	0	8,055,000		0	0	10,463,000		0	0	10,648,000		0	0	10,957,000			0	8,569,000		0	0	10,173,000		0	0	9,066,000															0
cash and cash equivalents at end of period	17,939,000	496,000	80,697,000		-5,580,000	64,359,000	5,242,000		13,628,000	382,000	291,000		30,041,000	-929,000	1,208,000		-17,285,000	4,639,000	13,488,000		-2,788,000	-6,365,000	12,599,000		-15,372,000	6,544,000	18,286,000		-4,494,000	-62,000	32,621,000		-23,171,000	20,535,000	13,401,000		16,478,000	8,353,000	1,876,000		15,905,000	1,214,000	7,465,000	-1,561,000	2,135,000	7,158,000		6,538,000	5,010,000	20,905,000		-1,375,000	-2,739,000	8,946,000		-1,704,000	6,151,000	9,858,000			-3,005,000	13,305,000		466,000	-7,550,000	19,087,000		7,825,000	1,287,000	3,525,000							-1,497,000	1,555,000							3,856,000
deferred income tax (benefit) expense				1,002,000						107,000	-597,000									-282,000	14,000						-3,146,000													-157,000						681,000
loss on early extinguishment of debt								0	0			1,816,000	0														360,000	43,000				0	0	0	4,969,000	0	0												0	1,419,000																																			0
acquisitions, net of cash acquired																-2,406,000	0															0
acquisition-related settlements										0	182,000															26,000	-136,000	-2,000	-123,000	-2,000	-24,000	-53,000							277,000
principal payments on term loan								0	0			-50,000,000	0	-50,001,000	-437,000	-438,000								-71,376,000	0
principal payments on note payable												0	0	0	-2,426,000	0	0	-1,000	-2,425,000	0	0
debt issuance costs												-78,000	0	-67,000	-3,092,000	-1,525,000	-108,000										-568,000					0				0	-192,000							-148,000			95	0	0	-506,000			0	-44,000					-98	0							525	-2,436,000
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
supplemental disclosure of cash flow information:
interest paid
income taxes paid
deferred income tax expense								674,000				2,265,000	-679,000	1,048,000	2,428,000		-126,000						31,000	-297,000	31,000				1,178,000	1,043,000	825,000		409,000	603,000	597,000				471,000			574,000	838,000	1,079,000			43,705,296	-310,000	200,000	2,305,000													10,217,802	-66,000	-795,000	-119,000		145,000	-282,000	103,000	3,008,518	3,808,000	-1,160,000	5,691,000	-1,195,068	2,808,000	3,003,000	2,423,000	779,908	967,000	1,421,000	1,478,000
proceeds from term loan																75,000,000	0
other investing activities																																																			-52,832	-52,000	-65,000	-89,000	-49,907	-48,000	-57,000	-43,000	-80,324
cash payments to noncontrolling shareholder																0				-185,000	-103,000	-321,000	-544,000													-223,000
other non-cash (benefits) costs
borrowings under revolving credit facility																	14,486,000	125,965,000	148,016,000		118,138,000	85,553,000	107,274,000																													15,100,000	6,000,000	1,200,000
repayments on revolving credit facility																	-26,476,000	-206,000,000	-105,400,000		-111,200,000	-104,100,000	-110,600,000									0															0	0	0	-10,000,000
proceeds under senior secured asset-based revolving credit facility
amortization of debt discount and debt issuance costs																																		75,000	354,000	413,000	413,000	432,000	470,000	475,000	475,000	470,000	466,000
non-cash gain on derivative liability
convertible note cash payment																																0
extinguishment fees																																0	0	0	-578,000	0	0
proceeds from senior secured asset-based revolving credit facility
other liabilities																											480,000	483,000	-251,000	-651,000	-178,000	865,000	-412,000	318,000	76,000	-128,000	1,609,000	220,000	-1,347,000	-44,000	478,000	197,000	255,000	2,896,000	-1,318,000	572,000	-190,160	1,024,000	49,000	657,000	70,065	294,000	293,000	999,000	-70,168	-53,000	-428,000	113,000	-128,805	263,000	-138,000	489,000										1,015,000
principal payments on term loans																											-7,500,000	-7,374,000	-6,250,000	-1,250,000	-1,250,000	0
gain on derivative liability																																	0	0	-1,581,000			3,571,000	-16,436,000			-362,000	-2,147,000
proceeds from sale of business																																				0
proceeds from term loans																																0
borrowings on revolving credit facility																																0
write-off of property and equipment
(gain) loss on derivative liability																																				14,165,000
acquisition-related contingent consideration																																		281,000	270,000	107,000	192,000	183,000	287,000
other noncash costs, including loss on sale of business
transaction costs related to sale of business																																								0
repayments of debt																																		-504,000	-6,005,000
borrowings on debt
acquisition-related settlements - mediscan																																				0	0
acquisition-related settlements - medical staffing network																																				0	0
proceeds from borrowing on senior credit facility																																				0	0
principal payment on senior credit facility
principal payments on second lien term loan																																				0	0
proceeds from borrowing on second lien term loan
proceeds from borrowing on convertible note																																												0
repayments of capital lease obligations																																				-11,000	-13,000	-20,000	-27,000	-28,000	-27,000	-26,000	-27,000
loss on sale of business
principal payment on term loan
cash payment to noncontrolling shareholder																																						-160,000	-172,000	-141,000	-106,000	-117,000	-130,000
repurchase of stock for tax withholdings																																							-214,000	0	-78,000	-400,000	-65,000
loss on derivative liability																																								9,516,000
loss on early extinguishment and modification of debt																																															10
gain on sale of business
other noncash costs																																													2,000	97,000
proceeds from sale of businesses																																								0
income tax refunds
acquisition, net of cash acquired
acquisition of assets of medical staffing network, net of cash acquired																																												448,000
bad debt expense																																											91,000	257,000	32,000	432,000	308,920	215,000	132,000	427,000	222,715	256,000	281,000	111,000	343,805	146,000	-149,000	238,000	178,795			211,000		-303,000	171,000	-95,000	263,711	203,000	0	484,000	293,626	0	480,000	785,000	437,368	0	150,000	-128,000	593,840	144,000	37,000	402,000	-198,700	0
operating activities
net income																																												-7,484,000	-3,182,000	-782,000	-52,584,323	914,000	-1,457,000	1,158,000	-9,533,497	-17,600,000	-14,504,000	-584,000	531,849	1,786,000	1,573,000	207,000	-6,003,863	916,000	1,178,000	1,135,000	398,308	968,000	2,292,000	3,036,000	-161,336,613	6,171,000	6,371,000	5,850,000	7,267,509	7,049,000	5,461,000	4,802,000	7,511,389	122,000	4,433,000	4,570,000	4,885,386	4,982,000	1,249,000	3,636,000	5,570,695	5,134,000	6,803,000
depreciation																																												1,005,000	817,000	974,000	933,688	890,000	1,040,000	1,022,000	1,194,184	1,220,000	1,559,000	1,593,000	1,597,677	1,548,000	1,804,000	1,841,000	1,887,548	1,782,000	2,221,000	2,153,000	2,128,088	2,034,000	2,306,000	2,305,000	2,284,712	1,789,000	1,777,000	1,786,000	1,950,538	1,370,000	1,505,000	1,484,000	1,428,441	1,315,000	1,383,000	1,322,000	1,607,513	1,206,000	1,215,000	1,130,000	1,170,984	1,024,000	1,230,000
amortization																																												1,011,000	784,000	785,000	610,077	552,000	566,000	566,000	941,743	803,000	819,000	818,000	818,408	833,000	877,000	965,000	963,867	963,000	963,000	961,000	971,968	1,005,000	1,018,000	1,023,000	1,136,797	713,000	643,000	673,000	690,311	622,000	370,000	369,000	440,005	418,000	356,000	356,000	355,629	356,000	356,000	356,000	599,582	526,000	991,000
amortization of debt issuance costs																																												97,000	52,000	57,000
amortization of debt discount
change in fair value of convertible note derivative liability
gain on sale of clinical trial services business																																															45,286	71,000	73,000	-4,158,000
other assets																																												206,000	617,000	-556,000		-612,000	5,308,000	-5,636,000		30,000	58,000	464,000		-620,000	183,000	-124,000
investing activities
proceeds from sale of clinical trial services business segment, net of cash sold and transaction costs
financing activities
principal repayments on term loan																																																0	0	-23,125,000
proceeds from borrowing on term loan																																												0							0
repayments on asset-based revolving credit facility																																												-29,304,000	-18,000,000	-9,700,000	-5,800,175	0	0	-49,244,000
borrowings under asset-based revolving credit facility																																												22,200,000	10,305,000	20,600,000	14,200,175	0	0	49,244,000
principal payments on capital lease obligations and note payable																																												-26,000	-28,000	-42,000		-102,000	-124,000	-225,000
repurchase of stock for restricted stock tax withholdings																																												-16,000				0				1,000				0				0
proceeds from sale of business segment, net of cash sold and transaction costs																																															-48,681	-193,000	-167,000	46,064,000
debt financing costs
acquisition of assets of on assignment, inc.
liquidation of foreign cash investments
repayments of capital lease obligations and note payable
supplemental disclosure of noncash investing and financing activities:
equipment purchased through capital lease obligations
insurance premium financing
impairment charge
share-based compensation																																																451,000	585,000	599,000		611,000	731,000	638,000		774,000	832,000	644,000
adjustments to reconcile net income
provided by operating activities:
see accompanying notes to the condensed consolidated financial statements.
loss on modification of debt																																																			-497
other noncash charges																																																					472,000	481,000	-683,168	240,000	239,000	227,000	-636,246	-1,097,000	838,000	715,000	-835,551	-229,000	789,000	765,000		432,000	339,000	237,000	-110,858	149,000	65,000	57,000	-145,445	48,000	43,000	265,000
net cash from (used by) operating activities
acquisition of mda holdings, inc.
repayments of revolving credit facility
repayment of capital lease obligations and note payable
supplemental disclosure of cash flow information
principal payments on short term debt
deferred and other financing costs
adjustments to reconcile net income to net cash provided by
operating activities:
repayment of debt																																																					-9,509,000	-3,508,000		-4,010,000	-2,246,000	-4,117,000		-1,245,000	-3,876,000	-6,772,000		-26,477,000	-35,595,000	-17,137,000		-17,089,000	-33,248,000	-35,680,000		-44,084,000	-35,344,000	-44,045,000		-9,326,000	-8,398,000	-8,862,000		-7,829,000	-29,788,000	-55,512,000		-23,630,000
adjustments to reconcile net income to net cash provided
by operating activities:
legal settlement charge																																																																											-2,122,608
acquisition of akos limited
exercise of stock options																																																															1,315,518	132,000			-127	900,000	92,000	22,000	247,214	263,000	243,000	1,146,000	955,797	11,000	105,000	221,000	244,564
tax benefit of stock option exercises																																																															78,194	12,000			-1,135	121,000	29,000	3,000	-17,033	29,000	15,000	250,000
release of restricted cash																																																															0
repayment of debt and note payable
proceeds from issuance of debt																																																													2,500,000	1,500,000	4,650,000	2,850,000	11,075,000	1,500,000	1,000,000	127,000,000	25,448,000	38,369,000	34,026,000	59,192,000	37,389,000	48,876,000	66,720,000	19,575,000	0	2,175,000	70,888,695	250,000	24,760,000	54,810,000	9,540,000	14,500,000	0
supplemental disclosure of noncash investing and financing activities
other acquisition related payments
borrowings under our revolving credit facility																																																									0	2,500,000
prepaid rent, deposits, and other assets
acquisition of mda holdings, inc., net of cash acquired
acquisition of assent consulting, net of cash acquired
acquisition of akos limited, net of cash acquired
acquisition of assets of metropolitan research associates, llc and metropolitan research staffing associates, llc
repurchase of stock for restricted tax withholdings
other current assets																																																												-2,693,000	370,000	210,000		4,044,000	3,066,000	450,000		-1,271,000	967,000	-728,000
change in cash and short-term cash investments
cash and short-term cash investments at beginning of period
cash and short-term cash investments at end of period
other comprehensive income, before tax
foreign currency translation adjustments
net change in fair value of hedging transactions
net change in fair value of marketable securities
income tax expense related to items of other comprehensive income
other comprehensive income, net of tax
comprehensive income
prepaid rent, deposits, and other current assets
accrued legal settlement charge																																																																							-392	0	0	-6,704,000
cash and short-term cash investments at beginning of year
cash and short-term cash investments at end of year
intangible assets subject to amortization:
databases
customer relations
non-compete agreements
trademark
intangible assets not subject to amortization:
goodwill
trademarks
other current liabilities																																																																121,000	68,000	26,000	-1,558,378	128,000	-198,000	664,000				681,000	945,479	301,000	-196,000	609,000							462,000
acquisition related payments																																																																	-7,514,000	-25,000			-4,501,000	-8,630,000
income from discontinued operations																																																																											-47,963	2,000	9,000	107,000	-47,033	-268,000	-77,000	-196,000
net cash from continuing operations																																																																							18,637,949	8,696,000	10,187,000	-1,557,000	3,112,983	9,609,000	9,849,000	10,098,000	9,444,959	11,319,000	6,715,000	3,380,000	8,404,384	10,266,000	14,901,000
net cash from discontinued operations																																																																											93,687	1,000	22,000	132,000	479,371	-105,000	-389,000	-54,000
other acquisitions and related payments
(income) income from discontinued operations																																																																											47,963	-2,000	-9,000	-107,000
noncash items
change in net assets from discontinued operations																																																																											9,646	0	34,000	199,000	308,839	194,000	80,000	-250,000			0
investing activities of discontinued operations:
other investing activities of discontinued operations																																																																															-30	0	0	-816,000
income taxes receivable and other assets
other noncash items																																																																												-1,000	-21,000	-174,000
other financing activities																																																																												-3,000	20,000	7,000			626,000	291,000		5,000
supplemental disclosures of noncash financing activities:
equipment purchased through financing agreements																																																																												0				485,000
income taxes and other assets
acquisitions																																																																									-8,945,000	-515,000
income taxes receivable and other current assets																																																																										-2,947,000			5,857,000	609,000
acquisition of assets of med-staff, inc.
acquisition and earnout payments related to discontinued businesses
net proceeds from sale of discontinued operations
financing activities of discontinued operations
income tax receivable and other current assets																																																																																	-14,043,000	491,000
additions of property and equipment																																																																												-2,579,000	-2,295,000	-1,550,000
loss (income) from discontinued operations																																																																															47,033	268,000	77,000	196,000
acquisition of assets of heritage professional education, llc
acquisition and earn out payments related to discontinued businesses
issuance of common stock in exchange for employee services
other non-cash charges																																																																																222,000	152,000	548,000
income taxes payable and other current liabilities
depreciation, amortization and bad debt expense
other non-cash items
acquisitions and earnout payments																																																																																				-68,000
earn out payments related to discontinued business
financing activities of discontinued operations:
other financing activities of discontinued operations
supplemental disclosures of noncash investing and financing activities:
income tax payable and other current liabilities																																																																																	-339,000	578,000
investing activites of discontinued operations:
amortization of unearned compensation																																																																																					16,000
other current liabilities and income taxes payable
gain on sale of consulting business
loss on impairment of discontinued operations
change in net assets of discontinued operations
acquisition of novapro assets
initial public offering costs
amortization of deferred compensation																																																																																				16,000
tax benefit from stock option exercises
discontinued operations, net of income taxes																																																																																					1,000
prepaid rent, deposits and other current assets
impairment loss on discontinued operations
investing activities of discontinued operations
acquistions
purchase of property and equipment
increase in software development costs
change in cash
cash at beginning of period
cash at end of period
revenue from services
net income per common share - basic and diluted

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.